#biotech
articles
Warhound: Billionaire-Backed Startup to Clone and Gene-Edit Military Dogs
Ben Lamm and Palmer Luckey launch Warhound, a startup that clones and genetically modifies military dogs to improve trai...
Biotech Stocks: A Promotional Landing Page, Not Investment Intelligence
A Dutch-language page titled 'Biotech stocks: investing in health' contains no stock list, no prices and no analysis — o...
Ladders to Cures Bets on 'Nodal Biology' to Make Rare Disease Drugs Profitable
A Harvard-led accelerator is hunting for shared biological mechanisms across rare diseases, aiming to build single drugs...
Former Pfizer R&D Chief Mikael Dolsten Joins Quantumcell Board
The ex-Pfizer research head joins the Danish biotech as the $12 million upfront payment for Alzecure's Alzheimer platfor...
Biotech investing: chasing the thrill of clinical success amid extraordinary risk
Biotechnology stocks have become a standalone investment theme, blending breakthrough science with extreme volatility. H...
arGEN-X to Acquire Forte Biosciences in $2.2 Billion Immunology Pipeline Deal
Dutch biotech arGEN-X is buying US-based Forte Biosciences for $2.2 billion, adding a promising anti-CD122 antibody for ...
Nobel Laureate Fred Ramsdell Says Biotech, Not Universities, Drives Breakthrough Medical Science
Immunologist Fred Ramsdell argues that biotech’s team-oriented mission beats university labs’ fragmented incentive struc...